Frontier Biotechnologies (SHSE:688221) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 28, 2026)


SHSE:688221 Frontier Biotechnologies Inc SHSE:688221
65 GF Score
Price ¥19.62
GF Value ¥37.60
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Frontier Biotechnologies Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Frontier Biotechnologies's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:688221 vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Frontier Biotechnologies's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frontier Biotechnologies Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Frontier Biotechnologies's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Frontier Biotechnologies's Margin of Safety % (DCF FCF Based) falls into.


SHSE:688221
65GF Score
Frontier Biotechnologies Inc SHSE:688221
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Frontier Biotechnologies (SHSE:688221) Overvalued in 2026?

Based on GuruFocus' analysis, Frontier Biotechnologies stock appears to be undervalued. The current stock price of ¥19.62 is trading 47.8% below its estimated GF Value™ of ¥37.60. GuruFocus considers Frontier Biotechnologies to be Significantly Undervalued.

Key valuation signals for SHSE:688221:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥37.60 vs. price of ¥19.62 (47.8% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688221 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Frontier Biotechnologies Business Description

Address Dongshan Street, 11th Floor, Building E-2, Greenland Window, Jiangning District, Jiangsu Province, Nanjing, CHN, 211199
Frontier Biotechnologies Inc is engaged in the Research, development, production, and marketing of inventive drugs that address unmet clinical needs.
65GF Score

Get the complete analysis for SHSE:688221

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.62
Price
¥37.60
GF Value